AB
AbbVie Inc.
NYSE : ABBVHealthcare · Pharmaceutical Preparations
Mkt Cap$466.45BShares Out1.77B30d Avg Vol16.74MShort Int—Short Float—IPODec 10, 2012
▲+5.13%
$5.74
–
| Form | Description | Filed |
|---|---|---|
| SD | Specialized Disclosure Report | Jun 30, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 24, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 22, 2026 |
| 8-K | 7.01 | Jun 19, 2026 |
| 10-Q | Quarterly Report5 | Jun 19, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 19, 2026 |
| 424B5 | Prospectus Supplement | Jun 19, 2026 |
| 8-K | 7.016 | Jun 19, 2026 |
| SC 13G | Beneficial Ownership Report | Jun 17, 2026 |
| SD | Specialized Disclosure Report | Jun 15, 2026 |
| 4 | Statement of Changes in Beneficial Ownership5 | Jun 15, 2026 |
| SD | Specialized Disclosure Report | Jun 11, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 9, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 9, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 9, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 4, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 31, 2026 |
| 8-K | 7.01 | May 31, 2026 |
| 3 | Initial Statement of Beneficial Ownership | May 31, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 31, 2026 |
| 13F-HR | Institutional Holdings Report | May 31, 2026 |
| 144 | Notice of Proposed Sale of Securities | May 26, 2026 |
| N-PX | Proxy Voting Record | May 26, 2026 |
| SC 13G | Beneficial Ownership Report | May 20, 2026 |
| 144 | Notice of Proposed Sale of Securities | May 18, 2026 |
1-25 of 210 filings
…